Table 5.
miRNA | Change | BIM-23014 | BIM-23A760 | BIM-53097 | |||
---|---|---|---|---|---|---|---|
FC | p-Value | FC | p-Value | FC | p-Value | ||
let-7a | → | 1.2 | 0.000 | 1.2 | 0.000 | −1.0 | NS |
let-7b | ↓ | −1.4 | 0.000 | −1.4 | 0.001 | −1.0 | NS |
let-7c | → | −1.0 | NS | 1.0 | NS | −1.1 | NS |
let-7d | → | −1.0 | NS | 1.0 | NS | 1.1 | NS |
let-7e | → | −1.2 | NS | −1.1 | NS | 1.1 | NS |
let-7f | ↑ | 1.8 | 0.002 | 2.1 | 0.000 | −1.2 | NS |
let-7g | ↑ | 1.7 | 0.001 | 1.9 | 0.000 | −1.1 | NS |
let-7i | ↑ | 1.3 | 0.000 | 1.4 | 0.000 | −1.1 | NS |
miR-98 | ↑ | 1.8 | 0.004 | 2.2 | 0.000 | −1.1 | NS |
The alteration in the expression of the let-7 family of miRNAs in NIH-H727 cells after 24 h treatment with somatostatin analogue BIM-23014, dopamine analogue BIM-53097 and the chimeric somatostatin-dopamine analogue BIM-23a760. N = 4, NS—p-value not significant.